HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

HSBA

1,179

-0.05%↓

LLOY

92.9

+0.74%↑

BARC

382.75

+0.41%↑

LSE

8,454

+0.64%↑

STAN

1,572

+0.77%↑

Inicio・Lista de Acciones・Scottish Mortgage Investment Trust PLC

Scottish Mortgage Investment Trust PLC

Cerrado

SectorFinanzas

1,163.5 -0.09

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1152

Máximo

1177.5

Métricas clave
By Trading Economics
Ingresos	1.7B 2.7B
Ventas	1.6B 2.7B
P/B Media del Sector	3.87 54.048
BPA	2.29
Rentabilidad por dividendo	0.37
Margen de beneficios	99.398
EBITDA	1.6B 2.7B

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	0.37% 4.84%
Próximas Ganancias	21 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	930M 13B
Apertura anterior	1163.59
Cierre anterior	1163.5

Noticias sobre sentimiento de mercado

By Acuity

50%

160 / 441 Clasificación en Finance

Scottish Mortgage Investment Trust PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 mar 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Charlas de Mercado

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Charlas de Mercado

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Charlas de Mercado

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Charlas de Mercado

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Charlas de Mercado

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Ganancias

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Noticias de Eventos Importantes

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Charlas de Mercado

Ganancias

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Scottish Mortgage Investment Trust PLC previsión

Sentimiento

By Acuity

160 / 441 Clasificación en Finanzas

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Scottish Mortgage Investment Trust PLC

Scottish Mortgage Investment Trust PLC is a United Kingdom-based investment trust. The Company’s investment objective is to maximize total return from a portfolio of long-term investments chosen on a global basis enabling the Company to provide capital and dividend growth. The Company invests in listed and private company securities and makes other investments so as to achieve its investment objective to maximize total return from a portfolio of long-term investments. It invests in various sectors, including consumer discretionary, technology, healthcare, industrials, financials, consumer staples, basic materials and energy. The Company invests in various geographical segments, including North America, Europe, Asia, South America, and Africa and Middle East. The Company’s Alternative Investment Fund Manager (AIFM) is Baillie Gifford & Co Limited.